Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway.
Lianglei JiangTing FangTingting HuJun FengPengfei Yan
Published in: Biology direct (2024)
The miR-338-3p/PI3K/Akt/THBS1 regulatory axis can modulate the progression of glioma cell proliferation and migration; thus, it can be considered a therapeutic biomarker.